27 results on '"Perez-Mancera, Pedro A."'
Search Results
2. Supplementary Table S12 from Tissue-Specific Oncogenic Activity of KRASA146T
3. Supplementary Tables S14-S17 from Tissue-Specific Oncogenic Activity of KRASA146T
4. Data from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
5. Data from Tissue-Specific Oncogenic Activity of KRASA146T
6. Supplementary Figures S1-S18 from Tissue-Specific Oncogenic Activity of KRASA146T
7. Supplementary Table 3 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
8. Supplementary Table 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
9. Supplementary Table 4 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
10. Data from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
11. Supplemental Methods from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
12. Supplementary Figure Legends, Supplementary Tables 1 and 2 and Supplementary Materials and Methods from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
13. Supplementary Figures 1 through 9 from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
14. Data from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
15. Supplementary Table 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
16. Supplementary Figure 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
17. Supplementary Figure 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
18. Abstract C084: Oncogenic KRAS signaling drives the activation of tissue-resident fibroblasts and is required to maintain CAF heterogeneity in pancreatic cancer
19. Abstract 3647: Oncogenic Kras drives cancer-associated fibroblast heterogeneity and substate changes in pancreatic cancer
20. Tissue-Specific Oncogenic Activity of KRASA146T
21. Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
22. Abstract A23: A second site KrasG12D mutation that impairs PI3K binding rescues embryonic lethality, abrogates myeloproliferative disease, and delays lung tumorigenesis
23. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
24. Tissue-Specific Oncogenic Activity of KRASA146T
25. Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
26. Abstract 798: Clonal analysis and clinical translation of pancreatic adenocarcinoma genomes.
27. Abstract SY08-01: Large-scale screens for cancer genes in the mouse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.